Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPACK Block with Dexamethasone for TKA Pain Control
NCT04917055Phase 4Terminated
- Sponsor
- University of California, San Diego
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine and dexamethasone in postoperative pain (2 arms), sponsored by University of California, San Diego. Primary endpoints: Average Opioid Use POD 0-1 at 24 hours, Average Pain Score at Rest POD 0-1 at 24 hours and 1 more. Started Jun 2021; status: terminated.
02
Drugs
ropivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04917055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04917055.